富蘭克林坦伯頓全球投資系列-生技領航基金美元F(acc)股
10.87美元0.07(0.64%)
2023/12/08更新
績效 / 1月6.42%
3月1.2%
1年3.31%
晨星評等-
- 1.現金3.87%
- 2.股票10.86%
- 3.債券0.00%
- 4.其他85.27%
- 1.美國84.31%
- 2.英國4.22%
- 3.新興亞洲3.86%
- 4.歐元區2.05%
- 5.歐洲不包含歐元區0.49%
- 1.Amgen Inc8.12%
- 2.Vertex Pharmaceuticals Inc7.48%
- 3.Regeneron Pharmaceuticals Inc7.23%
- 4.Biogen Inc5.09%
- 5.Gilead Sciences Inc4.65%
- 6.AstraZeneca PLC ADR3.98%
- 7.Jazz Pharmaceuticals PLC3.93%
- 8.Ascendis Pharma A/S ADR3.86%
- 9.Federal Home Loan Banks 0%3.40%
- 10.argenx SE ADR3.12%
- 1.現金3.87%
- 2.股票10.86%
- 3.債券0.00%
- 4.其他85.27%
- 1.美國84.31%
- 2.英國4.22%
- 3.新興亞洲3.86%
- 4.歐元區2.05%
- 5.歐洲不包含歐元區0.49%
- 1.Amgen Inc8.12%
- 2.Vertex Pharmaceuticals Inc7.48%
- 3.Regeneron Pharmaceuticals Inc7.23%
- 4.Biogen Inc5.09%
- 5.Gilead Sciences Inc4.65%
- 6.AstraZeneca PLC ADR3.98%
- 7.Jazz Pharmaceuticals PLC3.93%
- 8.Ascendis Pharma A/S ADR3.86%
- 9.Federal Home Loan Banks 0%3.40%
- 10.argenx SE ADR3.12%